Agilent Technologies Inc. (A1GI34) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Agilent Technologies Inc. BRL 29.47, price BRL 87.99, upside -66.5%, quality 69 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Agilent Technologies Inc. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range R$51.30 – R$89.46 · fair‑value band R$18.73 – R$43.07 · the R$87.99 price screens above the R$29.47 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.
Follow Agilent Technologies in your weekly email
Every Wednesday you see whether Agilent Technologies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.
Show more
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Stock analysis
Agilent Technologies Inc. (A1GI34) currently trades at R$87.99, while our model-based Fair Value estimate is R$29.47, 66.5% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of R$44.05 per share, and 0 of the 25 models we run sit above the R$87.99 price.
Bear case: the Dividend Discount group reads lowest at R$7.34, and 25 of the 25 models stay below the price. Evidence for this calculation is medium.
Scenario range: R$18.73 (bear) to R$43.07 (bull), the price of R$87.99 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 69/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Agilent Technologies Inc. reported revenue of $6.9B in FY2025 versus $6.3B in FY2021, a compound +2.4%/yr. Reported net income was $1.3B in FY2025, compounding +1.9%/yr from FY2021.
Key figures
Market cap R$194B (≈ $37.2B) · P/E ratio 26.6 · P/S ratio 4.99 · EPS (TTM) R$12.92 · Dividend yield 0.3% · Net margin 18.8% · Return on equity 21.3% · Return on assets (EBIT) 13.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 2% below its 52-week high and 61% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −6% fair-value upside, at −67%, A1GI34 screens richer than that median.
Fair Value models
Bear R$18.73Fair Value R$29.47Bull R$43.07
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 11 months old). Earnings retained since then (R$11.00 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.80/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+6.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.4%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.1%
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+6.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+5.8%
Dividend (yield on the price)0.3%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 22%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−8.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+5.7%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −10.4% a year for the price and +3.2% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (99 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Positive
Recent news coverage is more positive than average.
Compare Agilent Technologies Inc. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 134 stocks
Beats the industry median on 8/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score69 · Top 25%
Profitability
Return on equity (TTM)21.3% · Top 25%
Return on assets8.6% · Top 25%
Net margin (TTM)19.6% · Top 25%
Operating margin (TTM)23.7% · Top 25%
Growth and dividend
Revenue growth10.0% · Above median
Dividend yield (TTM)0.3% · Bottom 25%
Balance sheet
Debt / equity0.45× · Highest 25%
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
P/E (TTM)26.6× · Cheaper than median
PEG1.17× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)50· sector 22
PAST (return on equity)85· sector 11
HEALTH (low debt)77· sector 93
DIVIDEND (yield)6· sector 30
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Agilent Technologies Inc. Fair Value". https://www.fairvalue-calculator.com/stock/A1GI34
Frequently asked questions
Is Agilent Technologies Inc. (A1GI34) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of R$29.47 versus a price of R$87.99, about −67% upside (overvalued).
What is the fair value of A1GI34?
Our model-based fair value for Agilent Technologies Inc. is R$29.47 (as of Oct 3, 2026), built from audited fundamentals. The current price: R$87.99.
What is the quality score of A1GI34?
Agilent Technologies Inc. has a Quality Score of 69/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Agilent Technologies Inc. (A1GI34)?
Our model-based price target is the fair value of R$29.47 (as of Oct 3, 2026) from 25 valuation models. Cautious scenario R$18.73, optimistic scenario R$43.07. It is a calculation from audited fundamentals, not an analyst target.
What is the Agilent Technologies Inc. stock forecast for 2026?
Our models put fair value at R$29.47, about −67% upside versus a price of R$87.99 (overvalued). Cautious scenario R$18.73, optimistic scenario R$43.07. The calculation is refreshed regularly with new filings.
What is the revenue of Agilent Technologies Inc. (A1GI34)?
Agilent Technologies Inc. reported trailing-twelve-month revenue of about $7.2B (latest available figure, as of Oct 3, 2026).
Does Agilent Technologies Inc. pay a dividend?
Agilent Technologies Inc. currently shows a dividend yield of about 0.29% relative to its recent price (as of Oct 3, 2026).
What growth is priced into Agilent Technologies Inc. (A1GI34)?
For today's price to be fair in a discounted-cash-flow model, Agilent Technologies Inc. would have to grow free cash flow by -8.3 % per year for five years (discount rate 13.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +5.4 % per year. As of Oct 3, 2026.
What discount rate (WACC) does the fair value of A1GI34 use?
Our models discount Agilent Technologies Inc. at 13.0 %: a base by market capitalisation (large), damped by beta 1.26, country premium for Brazil. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Agilent Technologies Inc. that is -8.3 % per year a year over ten years, using the same discount rate (13.0 %) and the same formula as our fair value.
How much growth has Agilent Technologies Inc. (A1GI34) delivered so far?
Over the past 5 years revenue at Agilent Technologies Inc. grew +5.4 % a year. The price currently implies -8.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Agilent Technologies Inc. (A1GI34) growing?
The median revenue growth in the sector is +5.2 % a year. That is the yardstick for the growth priced into Agilent Technologies Inc. (-8.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Agilent Technologies Inc. (A1GI34)?
The free-cash-flow yield on the price is 24.16 %: that much free cash flow Agilent Technologies Inc. produces per unit of market value. When it exceeds the discount rate of our models (13.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Agilent Technologies Inc. (A1GI34)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Agilent Technologies Inc. it is R$29.47 per share (as of Oct 3, 2026), against a price of R$87.99. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).
Is Agilent Technologies Inc. stock overvalued or undervalued in 2026?
As of Oct 3, 2026, A1GI34 trades above its calculated fair value: price R$87.99, fair value R$29.47, a gap of about −67% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of A1GI34?
No. The price is what the market pays today (R$87.99); the fair value is what the company's own numbers justify (R$29.47). For Agilent Technologies Inc. the two are R$58.52 per share apart. That gap is exactly why we show both numbers side by side.
How much is Agilent Technologies Inc. worth?
The market values Agilent Technologies Inc. at about R$194B (market capitalisation, as of Oct 3, 2026). Per share that is R$87.99; our models calculate a fair value of R$29.47 per share.
What do the bullish and bearish scenarios say about A1GI34?
Our models span a range for Agilent Technologies Inc.: cautious scenario R$18.73, base R$29.47, optimistic R$43.07 per share (as of Oct 3, 2026, price R$87.99). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of A1GI34?
Agilent Technologies Inc. trades at a price-to-earnings ratio of 26.6 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of R$29.47 is built from several models across several years. Other multiples: PEG 1.2.
What is the PEG ratio of A1GI34?
The PEG ratio of Agilent Technologies Inc. is 1.17 (P/E divided by earnings growth, as of Oct 3, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Agilent Technologies Inc. (A1GI34)?
Balance-sheet figures for Agilent Technologies Inc. (as of Oct 3, 2026): return on equity 21.3%, debt of 0.45 per unit of equity. They feed the Quality Score of 69/100, which measures business quality independently of the share price.
How far is A1GI34 from its 52-week high?
Agilent Technologies Inc. trades at R$87.99, about 2% below its 52-week high of R$89.46 and 61% above the low of R$54.49 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of R$29.47 is for.
Which stocks are comparable to Agilent Technologies Inc.?
From the same area (Healthcare) we also value Thermo Fisher Scientific Inc, Danaher Corporation, WuXi AppTec Co, Lonza Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Agilent Technologies Inc. stock attractive at the current price?
The data as of Oct 3, 2026: price R$87.99, calculated fair value R$29.47 (−67%), Quality Score 69/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of A1GI34 calculated?
We run Agilent Technologies Inc. through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of R$29.47, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Agilent Technologies Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Agilent Technologies Inc. (A1GI34)?
The closing price on Oct 2, 2026 was R$87.99. Our model-based fair value is R$29.47, about −67% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Agilent Technologies Inc. right now?
The price sits above even our optimistic bull case (R$43.07). The favourable scenario is already priced in. Solid but not exceptional quality (69/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (R$18.73 to R$43.07) leaves room in how you read the outcome.
Key figures of Agilent Technologies Inc.
How large is the market capitalisation of Agilent Technologies Inc. (A1GI34)?
The market capitalisation of Agilent Technologies Inc. is R$194B (≈ $37.2B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Agilent Technologies Inc. (A1GI34)?
The price-to-sales ratio of Agilent Technologies Inc. is 4.99 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Agilent Technologies Inc. (A1GI34)?
Earnings per share at Agilent Technologies Inc. are R$12.92 (price ÷ EPS = P/E 26.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Agilent Technologies Inc. (A1GI34)?
The dividend yield of Agilent Technologies Inc. is 0.3% (payout 2.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Agilent Technologies Inc. (A1GI34)?
The net margin of Agilent Technologies Inc. is 18.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Agilent Technologies Inc. (A1GI34)?
The return on equity (ROE) of Agilent Technologies Inc. is 21.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Agilent Technologies Inc. (A1GI34)?
On an EBIT basis the return on assets of Agilent Technologies Inc. is 13.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Agilent Technologies Inc. (A1GI34)?
The operating margin of Agilent Technologies Inc. is 23.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Agilent Technologies Inc. (A1GI34)?
Revenue at Agilent Technologies Inc. is growing +10.0% versus a year earlier (3y avg +0.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Agilent Technologies Inc. (A1GI34)?
Earnings per share at Agilent Technologies Inc. are growing +60.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Agilent Technologies Inc. (A1GI34) carry?
The net debt of Agilent Technologies Inc. is $1.6B (fiscal year 2025, ≈ 1.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Agilent Technologies Inc. in the live analysis
One click puts Agilent Technologies Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
